Add BrightSurf on Google Email

The new Human Microglia Atlas provides insights on the roles of these immune cells in neurodegenerative diseases

The study provides insights into the roles of microglia in neurodegenerative diseases, revealing nine transcriptionally distinct subpopulations. The GPNMB-high Lipo.DAM signature is associated with Alzheimer's Disease and Multiple Sclerosis, and may hold relevance for immune-based therapies.

SourceJosep Carreras Leukaemia Research Institute·JournalNature Communications·TypeExperimental study·DateJan 17, 2025

Ultrasound-directed microbubbles could boost immune response against tumours, new Concordia research suggests

Concordia researchers propose a novel method using ultrasound-guided microbubbles to stimulate critical cytokine secretion in T cells, potentially re-activating them and increasing the release of proteins needed to fight cancer. The approach could complement existing treatments and improve outcomes.

SourceConcordia University·JournalFrontiers in Immunology·TypeExperimental study·DateJan 15, 2025

New research reveals how the body clock regulates inflammation

Researchers at RCSI University of Medicine and Health Sciences have discovered that macrophages, a type of immune cell, work differently throughout the day due to the body's internal clock. This daily rhythm determines when immune cells are most efficient at detecting threats and mounts a response.

SourceRCSI·JournalThe FASEB Journal·DateDec 17, 2024

Wyss Institute’s iNodes team receives ARPA-H Sprint for Women’s Health award to advance the first implantable immune organs to treat ovarian cancer

The Wyss Institute's iNodes team has been awarded an ARPA-H Sprint for Women's Health to develop implantable immune organs for treating ovarian cancer. The iNodes concept is based on the formation of lymphoid organs in tumors, which can be reprogrammed to attack cancer cells and retain a long-term immune memory.

How immune cells “sniff out” pathogens

Researchers from the University of Bonn have developed a new method to study immune receptors using a label-free biosensor assay. This approach allows for the detection of specific chemical signals that activate Toll-like receptors (TLRs), which are found on the surface of immune cells and play a crucial role in detecting infections. T...

SourceUniversity of Bonn·JournalNature Communications·DateNov 12, 2024

How vitamin D deficiency can lead to autoimmune diseases

A McGill University study reveals that vitamin D deficiency early in life can lead to a higher risk of autoimmune diseases like Type 1 diabetes. The research found that an aging thymus causes the immune system to become less effective, increasing the risk of misdirected immune cells attacking healthy tissues.

SourceMcGill University·JournalScience Advances·TypeExperimental study·DateOct 21, 2024

USC’s Rong Lu and Caltech’s Michael B. Elowitz win the NIH Director’s Transformative Research Award for their new approach to study blood and immune cell production in bone marrow

Researchers from USC and Caltech develop a new method to study hematopoietic stem and progenitor cells within the bone marrow without extracting them. This breakthrough could inform efforts to optimize bone marrow transplantation and provide insights into various health conditions, including cancer and heart disease.

Fever drives enhanced activity, mitochondrial damage in immune cells

Researchers found that fever temperatures increase helper T cell metabolism, proliferation and inflammatory activity, while causing mitochondrial stress, DNA damage and cell death in a specific subset of Th1 cells. These findings may explain how chronic inflammation contributes to cancer development and suggest a fundamental way cells ...

SourceVanderbilt University Medical Center·JournalScience Immunology·TypeExperimental study·DateSep 20, 2024

Low oxygen levels in tumors could enhance some of the body’s immune responses against cancer

A recent study by Dr. Esteban Ballestar's group identifies an immune cell population that is more effective in responding against cancer cells under hypoxia. Macrophages undergo changes that enhance their ability to trigger an immune response, leading to better patient outcomes in bladder and ovarian cancers.

SourceJosep Carreras Leukaemia Research Institute·JournalScience Advances·TypeExperimental study·DateSep 19, 2024

Proteins in meat, milk, and other foods suppress gut tumors

A new study published in Frontiers in Immunology reveals that certain food proteins like milk and meat can help keep gut tumors from growing by triggering the intestinal immune system. This discovery has potential clinical implications for patients with gastrointestinal conditions.

SourceRIKEN·JournalFrontiers in Immunology·DateSep 18, 2024

New study shows cells get involved in unhealthy relationships after acute kidney injury (AKI) in mice

Researchers have identified key cellular interactions and microenvironments that contribute to the development of chronic kidney disease (CKD) after acute kidney injury (AKI) in mice. The study, published in Nature Communications, provides new insights into how damaged cells interact within disease-promoting microenvironments.

SourceKeck School of Medicine of USC·JournalNature Communications·TypeExperimental study·DateSep 5, 2024

Fungal infection: A protein weakens the immune system

A study by researchers from Brazil and Germany found that a surface protein on Aspergillus fumigatus spores suppresses the release of pro-inflammatory substances by immune cells, making it easier for the fungus to infect the body. The enzyme glycosylasparaginase plays a crucial role in this process.

MCG scientists working to understand why men with prostate cancer are at higher risk of Alzheimer’s

Researchers investigated the connection between androgen deprivation therapy for prostate cancer and Alzheimer's disease. They found that ADT can exacerbate cognitive decline by increasing brain immune cell infiltration, but a combination with Natalizumab improved integrity of the blood-brain barrier and reduced inflammation.

Investigating the effect of alemtuzumab in allogeneic hematopoietic cell transplantation in patients with inborn errors of immunity

A study published in the Journal of Clinical Immunology found alemtuzumab to be safe and effective in treating Asian patients with inborn errors of immunity after allogeneic hematopoietic cell transplantation. The drug was shown to improve overall survival rates, with 94.7% of patients surviving post-transplantation.

SourceTokyo Medical and Dental University·JournalJournal of Clinical Immunology·DateJul 26, 2024